COVID-19 Vaccine: Considerations for UK Employers

Published date24 November 2020
Subject MatterLife Sciences,Biotechnology,Vaccinations,Pfizer,UK,Workplace Safety,Research and Development,Infectious Diseases,FDA Approval,Coronavirus/COVID-19
AuthorMatthew Howse,Lee Harding,Pulina Whitaker,Louise Skinner
Law FirmMorgan Lewis

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT